Inventor
Lawrence Helson
Inventor
Quakertown, PA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%
A61BDiagnosis2%
C07CAcyclic or carbocyclic compounds2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,739,353Suppression of cytokine release and cytokine storm202010,617,639Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current202010,532,045Liposomal mitigation of drug-induced inhibition of the cardiac I202010,485,768Treatment for glioblastoma201910,449,193Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies201910,357,458Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current201910,349,884Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel201910,258,691Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies201910,238,602Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies201910,117,881Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies201810,004,687Liposomal curcumin for treatment of diseases20189,682,041'Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current'20179,393,198'Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders'20169,170,257'Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin'20159,138,411'Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy'20158,784,881'Liposomal curcumin for treatment of diseases'20148,753,674'Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current'20148,747,890'Intravenous infusion of curcumin and a calcium channel blocker'20147,981,928'Chemotherapy method using x-rays'20116,667,346'Method for protecting cells and tissues from ionizing radiation toxicity with , unsaturated aryl sulfones'20035,696,153'Therapeutic regimen for treating patients'19975,688,517'Method for assessing sensitivity of tumor cells to cephalomannine and 10-deacetyltaxol'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997Patents assigned to NAPRO BIOTHERAPEUTICS INC (2)· patent assignee history
1997Based in Chappaqua, NY, US· patent location history
2003–2020Based in Quakertown, PA, US· patent location history
2014–2020Patents assigned to SIGNPATH PHARMA INC (18)· patent assignee history
2014–2016Patents assigned to HELSON LAWRENCE (4)· patent assignee history
2014–2018Patents assigned to UNIV TEXAS (2)· patent assignee history
2019–2020Patents assigned to AVANTI POLAR LIPIDS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNPATH PHARMA INC | 18 | 2014–2020 |
| HELSON LAWRENCEself | 4 | 2014–2016 |
| AVANTI POLAR LIPIDS INC | 2 | 2019–2020 |
| NAPRO BIOTHERAPEUTICS INC | 2 | 1997 |
| UNIV TEXAS | 2 | 2014–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Quakertown, Pennsylvania, US | 20 | 2003–2020 |
| Chappaqua, New York, US | 2 | 1997 |